Profile data is unavailable for this security.
About the company
Biofil Chemicals and Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing and trading pharmaceutical products. The Company operates through two segments: the Pharmaceutical Division and the Chemicals Division. It is also involved in the business activity of producing plastic products, which are used for the purpose of packing pharmaceutical product and other plastic products. The Company’s product categories include Basic Drugs & Chemicals, and Plastic Dripper & Caps. Its Basic Drugs & Chemicals include Sodium Chloride, Potassium Chloride, Sodium Citrate, Diethyl Carbamazine Citrate, Ferrous Sulphate, Dried Ferrous Sulphate, Ferrus Fumerate, Micro Crystalline Cellulose and Dicyclomine Hydrochloride. The Company's plants are located at Kheda Industrial Estate, Pithampur District, Dhar, and Sanwer Road, Industrial Area, Indore in Madhya Pradesh. The Company also deals in providing job work facilities in respect of the manufacturing of pharmaceutical drugs.
- Revenue in INR (TTM)384.48m
- Net income in INR6.69m
- Incorporated1985
- Employees--
- LocationBiofil Chemicals and Pharmaceuticals Ltd11/12 Sector E Sanwer RoadINDORE 452015IndiaIND
- Phone+91 7 312426700
- Fax+91 7 312723017
- Websitehttps://www.biofilgroup.net/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zenith Drugs Ltd | -100.00bn | -100.00bn | 1.10bn | -- | -- | 4.85 | -- | -- | -- | -- | -- | 13.21 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8679 | -- | 0.5617 | -- | 24.95 | -- | 64.70 | -- | -- | -- |
| Biofil Chemicals and Pharmaceuticals Ltd | 384.48m | 6.69m | 1.15bn | -- | 170.94 | -- | 104.21 | 2.98 | 0.4118 | 0.4118 | 23.91 | -- | -- | -- | -- | -- | -- | 2.86 | -- | 5.39 | 6.82 | 11.61 | 1.74 | 2.97 | -- | 27.03 | -- | -- | 34.19 | 19.43 | -19.76 | 3.55 | -51.09 | -- |
| Lasa Supergenerics Ltd | 1.17bn | -214.42m | 1.28bn | 89.00 | -- | -- | -- | 1.10 | -4.28 | -4.28 | 23.30 | -- | -- | -- | -- | 13,128,270.00 | -- | -2.61 | -- | -3.75 | 29.74 | 32.34 | -18.35 | -3.67 | -- | -0.949 | -- | -- | -5.51 | -12.02 | -624.41 | -- | -- | -- |
| Sotac Pharmaceuticals Ltd | 579.83m | 44.96m | 1.36bn | 89.00 | 22.04 | 8.60 | 22.20 | 2.34 | 5.58 | 5.58 | 60.69 | 14.31 | -- | -- | -- | -- | -- | -- | -- | -- | 30.90 | -- | 7.75 | -- | 0.9968 | 8.62 | 0.4806 | -- | -20.74 | -- | 56.17 | -- | -- | -- |
| Ind Swift Ltd | 4.73bn | 297.88m | 1.37bn | 1.67k | 4.63 | -- | 2.40 | 0.2904 | 5.48 | 5.48 | 87.46 | -- | -- | -- | -- | -- | -- | -1.11 | -- | -- | 43.41 | 46.03 | 6.30 | -1.95 | -- | 0.2304 | -- | -- | 3.33 | 8.72 | 230.05 | -- | 38.00 | -- |
